Clinical Studies

MERLOT

This pivotal study began in the United Kingdom in Q1, 2009. It is a head-to-head comparison of NeoVista epimacular beta radiation therapy and standard-of-care treatment with Lucentis. Patient enrollment (n=363) is expected to be completed in Q4, 2011.